DarioHealth Corp (DRIO) USD0.0001

Sell:$0.60Buy:$0.64$0.01 (1.31%)

Prices delayed by at least 15 minutes
Sell:$0.60
Buy:$0.64
Change:$0.01 (1.31%)
Prices delayed by at least 15 minutes
Sell:$0.60
Buy:$0.64
Change:$0.01 (1.31%)
Prices delayed by at least 15 minutes

Company Information

About this company

DarioHealth Corp. is a global digital therapeutics (DTx) company. The Company operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and highly engaging digital therapeutic interventions. Its platform and suite of solutions delivers personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its products include Dario Blood Pressure Monitoring System and Dario Blood Glucose Monitoring Starter Kit. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows to store all its user readings in the Dario App. Its Dario mobile app is a complete, cloud-based solution for personal chronic condition management.

Key people

Erez Raphael
Chief Executive Officer, Director
Zvi Ben-David
Chief Financial Officer, Treasurer, Secretary
Tomer Ben-Kiki
Chief Operating Officer
Steven Nelson
Chief Commercial Officer
Yoav Shaked
Independent Chairman of the Board
Adam K. Stern
Director
Jon Kaplan
Independent Director
Hila Karah
Independent Director
Dennis Matheis
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    US23725P2092
  • Market cap
    $21.48m
  • Employees
    249
  • Shares in issue
    34.10m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.